Corporate Tech Investors

Ascletis

Ascletis is a corporate VC investing group that makes strategic investments in firms that align with the company's business objectives.

Venture Investor Overview

Contact Information

Background Information

Overview

Ascletis is an innovative R&D driven biotech and listed on Hong Kong Stock Exchange (1672.HK). Ascletis is committed to developing and commercializing innovative drugs in the areas of viral hepatitis, NASH and HIV/AIDS for unmet medical needs in China and globally. Led by a management team with deep expertise and a proven track record, Ascletis has developed into a fully integrated platform covering the entire value chain from discovery and development to manufacturing and commercialization.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

2/17/2021

Transaction History

Our records indicate that Ascletis invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Jinzi Wu

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Ascletis has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Ascential | Ascot Group

Share this article

About Our List of Corporations Investing in Tech Companies

The strategic investor data above is provided by VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary